远大医药(00512)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00512 远大医药

休市中 05-02 16:08:25

5.930

-0.030

-0.50%

最高5.960	最低5.790	成交量125.10万
今开5.960	昨收5.960	日振幅2.85%
总市值210.49亿	流通市值210.49亿	总股本35.50亿
成交额734.41万	换手率0.04%	流通股本35.50亿
市净率1.28	ROE15.51%	每股收益0.70
52周最高6.260	52周最低3.862	市盈率8.41
股息0.26	股息收益率0.04	ROA5.84%

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00512","market":"HK","secType":"STK","nameCN":"远大医药","latestPrice":5.93,"timestamp":1746173305024,"preClose":5.96,"halted":0,"volume":1251000,"delay":0,"floatShares":3549571148,"shares":3549571148,"eps":0.704885,"marketStatus":"休市中","change":-0.03,"latestTime":"05-02 16:08:25","open":5.96,"high":5.96,"low":5.79,"amount":7344065,"amplitude":0.028523,"askPrice":5.93,"askSize":11000,"bidPrice":5.91,"bidSize":10000,"shortable":3,"etf":0,"ttmEps":0.704885,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746495000000},"marketStatusCode":7,"adr":0,"listingDate":819302400000,"exchange":"SEHK","adjPreClose":5.96,"dividendRate":0.043845,"openAndCloseTimeList":[[1746149400000,1746158400000],[1746162000000,1746172800000]],"volumeRatio":0.16330290956287022,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00512/wiki","defaultTab":"wiki","newsList":[{"id":"2532892118","title":"每日卖空追踪 | 远大医药 05月02日卖空量成交3.4万股，卖空比例为2.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532892118","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532892118?lang=zh_cn&edition=full","pubTime":"2025-05-02 16:30","pubTimestamp":1746174613,"startTime":"0","endTime":"0","summary":"远大医药北京时间05月02日，跌0.5%，卖空量成交3.4万股，较上一交易日减少95%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502163140a46fc9ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502163140a46fc9ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2531205352","title":"每日卖空追踪 | 远大医药 04月29日卖空量成交77.7万股，卖空比例为11.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531205352","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531205352?lang=zh_cn&edition=full","pubTime":"2025-04-29 16:53","pubTimestamp":1745916807,"startTime":"0","endTime":"0","summary":"远大医药北京时间04月29日，涨2.94%，卖空量成交77.7万股，较上一交易日增加55.56%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429171912a46bd5da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429171912a46bd5da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2530787453","title":"远大医药泌尿系统肿瘤早检产品首张处方落地 抢滩肿瘤早检市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2530787453","media":"证券日报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530787453?lang=zh_cn&edition=full","pubTime":"2025-04-27 21:37","pubTimestamp":1745761071,"startTime":"0","endTime":"0","summary":"本报讯（记者张敏）4月27日，港股上市公司远大医药集团有限公司（以下简称“远大医药”）发布的公告显示，公司与北京橡鑫生物科技有限公司（金橡医学）合作开发的泌尿系统肿瘤早检产品优爱?的首张商业化处方在上海复旦大学附属华东医院落地，标志着我国目前唯一获批上市的甲基化+基因突变双机制的尿路上皮癌早检产品正式进入临床应用，为我国患者提供更精准的无创肿瘤诊断服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504273390337959.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2530439896","title":"远大医药(00512.HK)：集团泌尿系统肿瘤早检产品在中国大陆实现首张商业化处方落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2530439896","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530439896?lang=zh_cn&edition=full","pubTime":"2025-04-27 18:16","pubTimestamp":1745748999,"startTime":"0","endTime":"0","summary":"格隆汇4月27日丨远大医药公告，近日，集团核药抗肿瘤诊疗板块与金橡医学合作开发的泌尿系统肿瘤早检产品优爱的首张商业化处方在上海复旦大学附属华东医院落地，标志着我国目前唯一获批上市的甲基化+基因突变双机制的尿路上皮癌早检产品正式进入临床应用，为中国患者提供更精准的无创肿瘤诊断服务。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/27181649929801.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2530436495","title":"从早筛到治疗全覆盖！远大医药(00512)双机制产品首张处方落地 龙头引领泌尿肿瘤诊疗革命","url":"https://stock-news.laohu8.com/highlight/detail?id=2530436495","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530436495?lang=zh_cn&edition=full","pubTime":"2025-04-27 18:16","pubTimestamp":1745748990,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，4月27日，港股科技创新型医药企业远大医药发布公告，公司核药抗肿瘤诊疗板块与北京橡鑫生物科技有限公司合作开发的泌尿系统肿瘤早检产品优爱的首张商业化处方在上海复旦大学附属华东医院落地，标志着我国目前唯一获批上市的甲基化+基因突变双机制的尿路上皮癌早检产品正式进入临床应用，为我国患者提供更精准的无创肿瘤诊断服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1285908.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"从早筛到治疗全覆盖！远大医药(00512)双机制产品首张处方落地 龙头引领泌尿肿瘤诊疗革命","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2530038869","title":"远大医药04月25日遭主力抛售124万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530038869","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530038869?lang=zh_cn&edition=full","pubTime":"2025-04-25 16:16","pubTimestamp":1745568992,"startTime":"0","endTime":"0","summary":"04月25日, 远大医药股价跌1.51%，报收5.86元，成交金额5201万元，换手率0.25%，振幅4.37%，量比1.16。远大医药今日主力资金净流出124万元，连续3日净流出，上一交易日主力净流出5万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为61.54%，平均跌幅为1.29%。该股近5个交易日上涨6.92%，主力资金累计净流入158万元；近20日主力资金累计净流入64万元，其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425170629a6c7cecb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425170629a6c7cecb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2529967623","title":"远大医药04月24日遭主力抛售5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529967623","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529967623?lang=zh_cn&edition=full","pubTime":"2025-04-24 16:17","pubTimestamp":1745482645,"startTime":"0","endTime":"0","summary":"04月24日, 远大医药股价跌0.83%，报收5.95元，成交金额4838万元，换手率0.23%，振幅3.67%，量比1.16。远大医药今日主力资金净流出5万元，上一交易日主力净流出20万元。该股近5个交易日上涨5.18%，主力资金累计净流入72万元；近20日主力资金累计净流入75万元，其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424170711a4651a30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424170711a4651a30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2529352898","title":"远大医药：丙酸氟替卡松鼻喷雾剂获批 脓毒症创新产品将于近期公布临床结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2529352898","media":"证券日报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529352898?lang=zh_cn&edition=full","pubTime":"2025-04-23 15:35","pubTimestamp":1745393734,"startTime":"0","endTime":"0","summary":"本报讯（记者金婉霞）4月22日，远大医药集团有限公司（下称“远大医药”）公告称，公司开发的丙酸氟替卡松鼻喷雾剂已获得国家药监局颁发的药品注册证书，该产品为国内首仿上市，并已进入国家医保目录和国家基本用药目录。丙酸氟替卡松鼻喷剂是国内过敏性鼻炎治疗的首选用药之一，长期以来以外资销售为主。此次远大医药推出的国内首仿上市产品，将有望打破外资产品的市场垄断。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504233385782212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2529659121","title":"港股异动 | 远大医药(00512)高开逾6% 中国首仿的丙酸氟替卡松鼻喷雾剂获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2529659121","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529659121?lang=zh_cn&edition=full","pubTime":"2025-04-23 09:26","pubTimestamp":1745371597,"startTime":"0","endTime":"0","summary":"消息面上，4月22日，远大医药发布公告，集团开发的用于治疗过敏性鼻炎的丙酸氟替卡松鼻喷雾剂近日获得中华人民共和国国家药品监督管理局(药监局)颁发的药品注册证书，该产品为中国首仿上市产品，且已被纳入国家医保目录和国家基本用药目录，此次，该产品的获批上市是集团在呼吸及危重症领域的又一次重大研发进展。据介绍，中国是世界上过敏性鼻炎发病率最高的国家之一。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282878.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2529322305","title":"2.5亿过敏性鼻炎患者福音!远大医药(00512)丙酸氟替卡松鼻喷雾获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2529322305","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529322305?lang=zh_cn&edition=full","pubTime":"2025-04-22 17:37","pubTimestamp":1745314651,"startTime":"0","endTime":"0","summary":"4月22日，远大医药公告称，公司开发的丙酸氟替卡松鼻喷雾剂已获得国家药监局颁发的药品注册证书，该产品为国内首仿上市，并已进入国家医保目录和国家基本用药目录。惠及2.5亿过敏性鼻炎患者，打破外资垄断市场格局中国是世界上过敏性鼻炎发病率最高的国家之一。该药物可与远大医药此次获批的丙酸氟替卡松鼻喷雾剂等形成产品组合，全面满足轻、中、重度过敏性鼻炎患者的用药需求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282291.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"2.5亿过敏性鼻炎患者福音!远大医药(00512)丙酸氟替卡松鼻喷雾获批上市","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2529252663","title":"远大医药(00512)：中国首仿的丙酸氟替卡松鼻喷雾剂获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2529252663","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529252663?lang=zh_cn&edition=full","pubTime":"2025-04-22 17:07","pubTimestamp":1745312877,"startTime":"0","endTime":"0","summary":"智通财经APP讯，远大医药 发布公告，集团开发的用于治疗过敏性鼻炎的丙酸氟替卡松鼻喷雾剂近日获得中华人民共和国国家药品监督管理局(药监局)颁发的药品注册证书，该产品为中国首仿上市产品，且已被纳入国家医保目录和国家基本用药目录，此次，该产品的获批上市是集团在呼吸及危重症领域的又一次重大研发进展。此次，集团丙酸氟替卡松鼻喷雾剂的首仿上市将有望进一步打破原研产品的市场垄断。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282253.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2529290853","title":"远大医药04月22日主力净流入470万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2529290853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529290853?lang=zh_cn&edition=full","pubTime":"2025-04-22 16:17","pubTimestamp":1745309850,"startTime":"0","endTime":"0","summary":"04月22日, 远大医药股价涨5.94%，报收5.89元，成交金额6924万元，换手率0.33%，振幅8.09%，量比2.14。远大医药今日主力资金净流入470万元，上一交易日主力净流出166万元。该股近5个交易日上涨4.25%，主力资金累计净流入95万元；近20日主力资金累计净流出333万元，其中净流出天数为13日。该股主力净额占比0.02%，港股市场排名236/2647。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422171823a6c38dc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422171823a6c38dc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2529139960","title":"港股医药强势领涨！恒生医药ETF涨超2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529139960","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529139960?lang=zh_cn&edition=full","pubTime":"2025-04-22 09:57","pubTimestamp":1745287039,"startTime":"0","endTime":"0","summary":"4月22日早盘，港股医药板块大涨，恒生生物科技指数涨超3%，恒生医药ETF（159892）盘中涨超2%，心泰医疗、诺诚健华、远大医药、先声药业等领涨。消息面来看，远大医药RDC药物临床研究取得里程碑式突破。国家卫健委宣布将于4月23日介绍推广三明医改经验、深化以公益行为导向的公立医院改革相关情况。此外，即将召开的AACR会议催化事件较为密集，有望进一步提振行业热度。据东吴证券数据，今年有126家中国药企亮相AACR会议，共发布近300项新药研究结果。恒生医药ETF联接（A类：016970，C类：016971）。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504221000459740026f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504221000459740026f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2529362150","title":"远大医药盘中异动 早盘股价大涨5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529362150","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529362150?lang=zh_cn&edition=full","pubTime":"2025-04-22 09:31","pubTimestamp":1745285478,"startTime":"0","endTime":"0","summary":"2025年04月22日早盘09时31分，远大医药股票出现波动，股价大幅拉升5.58%。远大医药股票所在的药品行业中，整体涨幅为0.21%。其相关个股中，三生制药、信达生物、远大医药涨幅较大，振幅较大的相关个股有石药集团、翰森制药、信达生物，振幅分别为4.50%、4.30%、4.23%。恒瑞医药子公司收到药物临床试验批准通知书。远大医药GPC-3靶向RDC临床数据全球首发。本次增持完成后，本集团持有复宏汉霖的股权比例将增至63.43%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422093118a461bfcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422093118a461bfcd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2529350459","title":"智通港股早知道 | 美元再跌、金价突破3400美元 国际资本正加速配置到香港和内地市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2529350459","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529350459?lang=zh_cn&edition=full","pubTime":"2025-04-22 07:28","pubTimestamp":1745278124,"startTime":"0","endTime":"0","summary":"香港财政司司长陈茂波：国际资本正加速配置到香港和内地市场智通财经APP获悉，香港财政司司长陈茂波4月20日发表网志表示，近期有不少金融市场的朋友表示，过去数月，国际资本正加速配置到香港和内地市场。美元再跌、金价突破3400美元 再创历史新高美元指数跌破98关口，为2022年3月以来首次。但地缘政治扰动催化全球央行及市场的黄金需求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1281984.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1188198961.HKD","SG9999006514.SGD","LU0516422952.EUR","LU0588545490.SGD","LU2097828714.EUR","LU0856984785.SGD","81211","BK1610","LU2476274308.USD","02498","BK1594","HYDD.SI","LU0588545730.USD","SG9999002463.SGD","SG9999015978.USD","LU1023057109.AUD","BK1506","LU0143863198.USD","YANG","002594","00762","LU0819121731.USD","LU0819123356.HKD","BK1536","SG9999015952.SGD","LU1794554557.SGD","LU1868837722.USD","LU0289960550.SGD","LU0540923850.HKD","LU0543330566.HKD","LU0463099449.HKD","BK1198","LU0561508036.HKD","LU0634319403.HKD","IE00BD6J9T35.USD","LU1868838027.USD","LU1720050803.USD","HSTECH","LU0823426308.USD","LU1861219969.SGD","LU0588545904.SGD","00512","LU1303224171.USD","BYDDY","LU0269904917.USD","LU1868837565.USD"],"gpt_icon":1},{"id":"2529656805","title":"远大医药：全球创新RDC药物GPN02006研发迎来新突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2529656805","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529656805?lang=zh_cn&edition=full","pubTime":"2025-04-21 20:17","pubTimestamp":1745237844,"startTime":"0","endTime":"0","summary":"每经AI快讯，远大医药公告称，集团合作开发的用于诊断肝细胞癌（HCC）的全球创新放射性核素偶联药物(RDC)GPN02006，在中国开展的研究者发起的临床研究（IIT临床研究），近日取得了里程碑式突破，并于成都2025未来XDC新药大会中公开发表了临床结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504213383222841.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504213383222841.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["00512","RDC","BK1191"],"gpt_icon":0},{"id":"2529803860","title":"港股公告掘金 | 中国联通(00762)发布2025年第一季度业绩 股东应占溢利59.3亿元 同比增长5.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529803860","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529803860?lang=zh_cn&edition=full","pubTime":"2025-04-21 20:08","pubTimestamp":1745237324,"startTime":"0","endTime":"0","summary":"【重大事项】：盛业(06069)与数字鲸达成战略合作 以智算算力赋能企业降本增效呷哺呷哺(00520)拟8900万元收购呷哺呷哺(中国)食品40%股权马鞍山钢铁股份(00323)：马鞍山钢铁拟引入投资者宝钢股份远大医药(00512)：全球创新放射性核素偶联药物GPN02006在中国开展的临床研究取得里程碑式突破瑞浦兰钧(00666)与御风未来将共同开发相应的飞机零部件工作 并达成eVTOL飞行器能","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1281699.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1969619763.USD","BK1191","BK0082","06936","BK1151","BK0010","BK1133","BK0164","BK0028","BK0188","BK1589","BK0006","00762","HSTECH","LU1064130708.USD","LU1580142542.USD","BK1506","YANG","BK0196","LU1781817850.SGD","BK4614","600050","BK1536","SG9999002463.SGD","LU2328871848.SGD","LU1064131003.USD","BK0261","LU2148510915.USD","00512"],"gpt_icon":1},{"id":"2529808143","title":"远大医药：全球创新RDC药物GPN02006研发迎来新突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2529808143","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529808143?lang=zh_cn&edition=full","pubTime":"2025-04-21 20:03","pubTimestamp":1745237014,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU2237443382.USD","BK4588","LU2237443622.USD","RDC.AU","HCC","BK4006","GPC","BK4159","LU2237443549.SGD","BK4585","LU2237443978.SGD","RDC","BK1191","00512"],"gpt_icon":0},{"id":"2529874382","title":"全球创新GPC-3靶向RDC临床突破！远大医药(00512)破解中国肝癌早诊难题，剑指肝癌精准诊疗百亿蓝海","url":"https://stock-news.laohu8.com/highlight/detail?id=2529874382","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529874382?lang=zh_cn&edition=full","pubTime":"2025-04-21 18:52","pubTimestamp":1745232777,"startTime":"0","endTime":"0","summary":"直击肝细胞癌精准诊疗痛点，GPC-3靶向突破领跑全球原发性肝癌中是全球第六大常见癌症和第三大癌症死亡原因。因此，对HCC患者精准诊断和精准治疗，是提高患者预后、降低患者死亡风险的重要手段。此外，针对GPC-3靶点的治疗类RDC产品也已列入公司的研发计划中，有望实现对HCC患者的RDC诊疗一体化。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1281594.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4585","00512","LU2237443549.SGD","RDC","LU2237443382.USD","BK4159","BK1191","LU2237443622.USD","GPC","BK4588","LU2237443978.SGD"],"gpt_icon":0},{"id":"2529714038","title":"远大医药(00512)：全球创新放射性核素偶联药物GPN02006在中国开展的临床研究取得里程碑式突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2529714038","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529714038?lang=zh_cn&edition=full","pubTime":"2025-04-21 18:46","pubTimestamp":1745232377,"startTime":"0","endTime":"0","summary":"智通财经APP讯，远大医药 发布公告，集团与武汉睿迪辐生物科技有限公司、杰科(天津)生物医药有限公司合作开发的用于诊断肝细胞癌的全球创新放射性核素偶联药物 GPN02006在中国开展的研究者发起的临床研究，近日取得了里程碑式突破，并于成都2025未来XDC新药大会中公开发表了临床结果。集团将继续积极推进GPN02006产品的全球研发进程，争取实现中美两国注册性临床研究同步开展，并获得FDA突破性疗法认证。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1281587.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"远大医药(00512)：全球创新放射性核素偶联药物GPN02006在中国开展的临床研究取得里程碑式突破","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","00512"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chinagrandpharm.com","stockEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":-0.0123},{"period":"3month","weight":0.47},{"period":"6month","weight":0.3483},{"period":"1year","weight":0.3907},{"period":"ytd","weight":0.2922}],"compareEarnings":[{"period":"1week","weight":0.0238},{"period":"1month","weight":-0.0301},{"period":"3month","weight":0.1127},{"period":"6month","weight":0.0974},{"period":"1year","weight":0.236},{"period":"ytd","weight":0.1219}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"远大医药健康控股有限公司是一家主要从事制造及销售医药制剂及医疗器械的香港投资控股公司。该公司主要从事制造及销售医药制剂及医疗器械、生物技术产品及营养产品、精品原料药和其他产品。该公司的主要产品涵盖抗肿瘤、心血管急救制剂及高端心脑血管介入医疗器械、抗病毒抗感染、呼吸及五官科以及生物健康产品和精品原料药。","yearOnYearQuotes":[{"month":1,"riseRate":0.466667,"avgChangeRate":0.087032},{"month":2,"riseRate":0.7,"avgChangeRate":0.108479},{"month":3,"riseRate":0.4,"avgChangeRate":0.019078},{"month":4,"riseRate":0.633333,"avgChangeRate":0.018767},{"month":5,"riseRate":0.433333,"avgChangeRate":0.069176},{"month":6,"riseRate":0.344828,"avgChangeRate":-0.050245},{"month":7,"riseRate":0.37931,"avgChangeRate":-0.016335},{"month":8,"riseRate":0.37931,"avgChangeRate":0.004561},{"month":9,"riseRate":0.482759,"avgChangeRate":-0.037401},{"month":10,"riseRate":0.517241,"avgChangeRate":-0.014293},{"month":11,"riseRate":0.517241,"avgChangeRate":0.088816},{"month":12,"riseRate":0.517241,"avgChangeRate":-0.006306}],"exchange":"SEHK","name":"远大医药","nameEN":"GRAND PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"远大医药(00512)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供远大医药(00512)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"远大医药,00512,远大医药股票,远大医药股票老虎,远大医药股票老虎国际,远大医药行情,远大医药股票行情,远大医药股价,远大医药股市,远大医药股票价格,远大医药股票交易,远大医药股票购买,远大医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"远大医药(00512)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供远大医药(00512)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}